Skip to main content

Registration
IDWeek Learning Objective
Return to Sessions
and Exhibits
Chasing the Sun
Schedule
Speakers
Oral Abstracts
Posters
Featured Speakers
FAQ

IDWeek 2020 Main banner

Registration
IDWeek Learning Objective
Return to Sessions
and Exhibits
Chasing the Sun
Schedule
Speakers
Oral Abstracts
Posters
Featured Speakers
FAQ

Tweets by IDWeek 2020

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Chasing the Sun

Live

On Demand

Favorite
0 Like
Facebook
Tweet this
Print

Jeffrey B. Locke, PhD

Sr. Director Microbiology
Cidara Therapeutics

Disclosure: Cidara Therapeutics, Inc. (Employee, Shareholder)

Poster(s):

1283 - New Generation Antiviral Conjugate (AVC): Stable, Safe, and Single
1284 - Outcomes by Baseline Pathogens and Susceptibility in the STRIVE Phase 2 Trial of Once-Weekly Rezafungin for Treatment of Candidemia and Invasive Candidiasis Compared with Caspofungin

Designed by CadmiumCD |Technical Support |Give Feedback
© Copyright 2024 CadmiumCD. All Rights Reserved.